Literature DB >> 18540496

Screening for sickle cell disease in newborns: recommendation statement.

.   

Abstract

Mesh：

Year:  2008        PMID： 18540496

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN： 0002-838X            Impact factor:   3.292


× No keyword cloud information.
  6 in total

1.  Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy.

Authors:  Elisa Ballardini; Anna Tarocco; Maria Marsella; Roberto Bernardoni; Gianni Carandina; Claudia Melandri; Giovanni Guerra; Alfredo Patella; Miranda Zucchelli; Alessandra Ferlini; Stefania Bigoni; Anna Ravani; Giampaolo Garani; Caterina Borgna-Pignatti
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

2.  Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis.

Authors:  Niti G Patel; Terianne Lindsey; Robert C Strunk; Michael R DeBaun
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

3.  Coverage and preventive screening.

Authors:  Daniella Meeker; Geoffrey F Joyce; Jesse Malkin; Steven M Teutsch; Anne C Haddix; Dana P Goldman
Journal:  Health Serv Res       Date:  2010-10-28       Impact factor: 3.402

Review 4.  A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.

Authors:  Jacob Fiocchi; Ivan Urits; Vwaire Orhurhu; Mariam Salisu Orhurhu; Stephen Giacomazzi; Briggs Hoyt; Alan D Kaye; Rachel J Kaye; Omar Viswanath
Journal:  Curr Pain Headache Rep       Date:  2020-03-21

5.  Mobile phone based clinical microscopy for global health applications.

Authors:  David N Breslauer; Robi N Maamari; Neil A Switz; Wilbur A Lam; Daniel A Fletcher
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

6.  Urban-rural disparities in colorectal cancer screening: cross-sectional analysis of 1998-2005 data from the Centers for Disease Control's Behavioral Risk Factor Surveillance Study.

Authors:  Allison M Cole; J Elizabeth Jackson; Mark Doescher
Journal:  Cancer Med       Date:  2012-10-30       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.